药物性耳毒性:综合综述与参考指南
本综述通过 Micromedex、Lexicomp、教科书及 PubMed/Cochrane 检索,识别出 194 种与耳毒性相关的全身用药,并按 A/B/C 证据等级评估其耳蜗毒性、前庭毒性和头晕风险。结果显示抗菌药、精神药物、降压/抗心律失常药、NSAIDs 和抗肿瘤药最常见,耳毒性的效应与严重程度因药物和患者风险因素而异。
要点
- 194种全身用药与耳毒性相关,最常见为抗菌药(53种)、精神药物(21种)、降压/抗心律失常药(19种)、NSAIDs(18种)和抗肿瘤药(16种)。
- 165种药物有耳蜗毒性证据(A级22、B级77、C级69),100种有前庭毒性证据(A级23、B级47、C级30)。
- 142种药物与头晕相关(A级50、B级76、C级16),临床需结合药物和患者风险因素评估耳毒性。
核心结论
- 耳毒性的效应和严重程度可因药物药理学和个体患者风险因素而差异极大。
研究设计与样本
- 通过 Micromedex、Lexicomp 和《Drug Induced Diseases》教科书中的药物不良反应报告识别目标药物,并补充检索 PubMed 和 Cochrane 数据库。
- 证据因果性分级为 A(随机对照临床试验)、B(非随机临床试验、前瞻性观察研究、队列研究、回顾性研究、病例对照研究和/或上市后监测研究)、C(病例报告/病例系列)。
主要发现
- 共识别 194 种与耳毒性相关的全身用药,最常见为抗菌药(53种)、精神药物(21种)、降压/抗心律失常药(19种)、NSAIDs(18种)和抗肿瘤药(16种)。
- 165种药物有耳蜗毒性证据(A级22、B级77、C级69)。
- 100种药物有前庭毒性证据(A级23、B级47、C级30)。
- 142种药物与头晕相关(A级50、B级76、C级16)。
- 综述还评估了耳局部用药的耳毒性证据。
临床怎么用
- 医疗从业者应了解常见药物的耳毒性风险,以便为患者做出更知情的管理决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: In an era of increasing polypharmacy, adverse drug effects such as ototoxicity have significant public health implications. Despite the availability of evidence, many health care professionals may not know the risk of ototoxicity in common medications. Therefore, the aim of this review is to provide a comprehensive, easy to use, ototoxic profile of medications with an assessment of supporting evidence. METHODS: Medications of interest were identified through adverse drug reaction reports derived from Micromedex (IBM), Lexicomp (Wolters Kluwer), and the textbook, Drug Induced Diseases: Prevention, Detection, and Management. Additional evidence was identified though a query of PubMed and the Cochrane database. Evidence of causality was graded according to the following: A (randomized, controlled clinical trials), B (nonrandomized clinical trials, prospective observational studies, cohort studies, retrospective studies, case-controlled studies, and/or postmarketing surveillance studies), and C (case reports/case series). RESULTS: A total of 194 systemically administered medications associated with ototoxicity were identified, most commonly antimicrobials (53), psychotropics (21), antihypertensive/antiarrhythmics (19), nonsteroidal antiinflammatory drugs (18), and antineoplastics (16). There was evidence of cochleotoxicity in 165 medications (evidence grading A [22], B [77], C [69]), vestibulotoxicity in 100 medications (evidence grading A [23], B [47], and C [30]), and dizziness in 142 medications (evidence grading A [50], B [76], and C [16]). In addition, a review of the evidence of ototoxicity in ototopical medications is also reviewed. CONCLUSION: The effect and severity of ototoxicity can vary immensely depending on pharmacological and individual patient risk factors. The intent of this comprehensive review was to help health care providers of all sectors obtain a deeper knowledge of drug-induced ototoxicity to make more informed management decisions for their patients.
引用
- Rizk HG, Lee JA, Liu YF, et al. Drug-Induced Ototoxicity: A Comprehensive Review and Reference Guide. Pharmacotherapy. 2020. PMID: 33080070. doi:10.1002/phar.2478
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。